Description
Release form
Cream for external use.
Indications
Fungal infections of the skin caused by dermatophytes, such as: Trichophyton, including: Trichophyton rubrum. Trichophyton mentagrophytes. Trichophyton verrucosum. Trichophyton violaceum. Microsporum canis. Epidermophyton floccosum.
Skin infections caused by yeast-like fungi, mainly of the genus Candida (e.g. Candida albicans).
Multicolored lichen (Pityriasis versicolor) caused by Pityrosporum orbiculare (Malassezia furfur).
Use during pregnancy and lactation
Due to the fact that there are no safety data on the use of terbinafine in pregnant women, Terbizil in this category of patients is used only in cases when the expected positive effect exceeds the potential risk.
Terbinafine is excreted in breast milk, so the use of the drug during lactation is contraindicated.
Composition of
1 g of cream for external use contains:
Active ingredient:
terbinafine 10 mg.
Excipients:
sodium hydroxide, benzyl alcohol,
sorbitan monostearate,
cetyl palmitate,
cetyl alcohol,
cetostearyl alcohol (cetyl alcohol 60%, stearyl alcohol 40%),
polysorbate 60,
isopropyl myristate,
purified water.
Dosing and administration of srdlk. The duration of treatment depends on the nature and severity of the disease.
Adults. Before applying the cream, it is necessary to clean and dry the affected areas. The cream is applied 1 or 2 times a day with a thin layer on the affected skin and adjacent areas and gently rubbed. For infections accompanied by diaper rash (under the mammary glands, in the interdigital spaces, between the buttocks, in the inguinal region), the place of application of the cream can be covered with gauze, especially at night.
Average duration of treatment
Dermatomycosis of the trunk, legs: 1-2 times a day, 1 week.
Dermatomycosis of the feet: 1-2 times a day, 2 weeks.
Candidiasis of the skin: 1-2 times a day, 1-2 weeks.
Multi-colored lichen: 1-2 times a day, 2 weeks.
Elderly patients do not require dose adjustment.
Side effects
Local reactions: when applying the cream rarely – itching, burning sensation or hyperemia at the site of application (requiring discontinuation of therapy).
Drug Interaction
The drug interaction of Terbizil in cream form has not been described.
Overdose
There is no data on a topical overdose of terbinafine when used topically.
Storage conditions
Store in a dark place at a temperature of 15 ° to 30 ° C.
Keep out of the reach of children.
Expiration
5 years.
Active Terbinafine is a substance
dosage form
dosage form
cream